Galantamine-Curcumin Hybrids as Dual-Site Binding Acetylcholinesterase Inhibitors
Galantamine (GAL) and curcumin (CU) are alkaloids used to improve symptomatically neurodegenerative conditions like Alzheimer’s disease (AD). GAL acts mainly as an inhibitor of the enzyme acetylcholinesterase (AChE). CU binds to amyloid-beta (Aβ) oligomers and inhibits the formation of Aβ plaques. H...
Main Authors: | Georgi Stavrakov, Irena Philipova, Atanas Lukarski, Mariyana Atanasova, Dimitrina Zheleva, Zvetanka D. Zhivkova, Stefan Ivanov, Teodora Atanasova, Spiro Konstantinov, Irini Doytchinova |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/25/15/3341 |
Similar Items
-
Discovery of a Novel Acetylcholinesterase Inhibitor by Fragment-Based Design and Virtual Screening
by: Georgi Stavrakov, et al.
Published: (2021-04-01) -
A Novel Galantamine-Curcumin Hybrid as a Potential Multi-Target Agent against Neurodegenerative Disorders
by: Rumyana Simeonova, et al.
Published: (2021-03-01) -
A galantamine–curcumin hybrid lacks the depressant side effect of acetylcholinesterase inhibitors
by: Ivanka Kostadinova, et al.
Published: (2024-12-01) -
A Novel Galantamine–Curcumin Hybrid Inhibits Butyrylcholinesterase: A Molecular Dynamics Study
by: Evdokiya Salamanova, et al.
Published: (2024-12-01) -
Virtual Screening and Hit Selection of Natural Compounds as Acetylcholinesterase Inhibitors
by: Mariyana Atanasova, et al.
Published: (2022-05-01)